Concentra Group Holdings Parent, Inc. (CON) AI Stock Analysis

• Market Cap: $2.64B
• Dividend Yield: 1.27%
• Average Volume (3M): 767.75K
• Price to Earnings (P/E): 17.0
• Beta (1Y): 0.51
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 8,758
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Equipment & Services
• EPS (TTM): 0.39
• Shares Outstanding: 128,170,200
• 10 Day Avg. Volume: 694,888
• 30 Day Avg. Volume: 767,747
• PEG Ratio: -1.80
• Price to Book (P/B): 9.19
• Price to Sales (P/S): 1.33
• P/FCF Ratio: 12.05
• Enterprise Value/Market Cap: 1.82
• Enterprise Value/Revenue: 2.30
• Enterprise Value/Gross Profit: 8.09
• Enterprise Value/Ebitda: 12.18
• 1Y Price Target: $27.33
• Price Target Upside: 34.76% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 65 Neutral
• Price Target: $21.50 ▲(6.02% Upside)

The score is driven primarily by solid-but-mixed fundamentals: improving leverage and decent revenue growth are offset by declining profitability margins and negative free-cash-flow growth. The earnings call adds support through raised guidance and strong volume/EBITDA growth, while technicals remain neutral-to-weak and valuation is reasonable rather than compelling.

Positive Factors

Revenue Growth

Strong revenue growth indicates successful market expansion and product adoption, enhancing the company's competitive position.

Strategic Acquisitions

Effective acquisition integration demonstrates the company's ability to enhance operational efficiencies and synergies, driving long-term growth.

Leadership in Data and AI

Strengthening leadership in data and AI aligns with growth priorities, potentially enhancing innovation and operational efficiency.

Negative Factors

Declining Profit Margins

Decreasing profit margins indicate potential challenges in cost management, which could impact long-term profitability.

Negative Free Cash Flow Growth

Negative free cash flow growth suggests potential cash flow challenges, which could limit financial flexibility and investment capacity.

Increased Administrative Expenses

Rising administrative expenses may strain profitability, requiring improved cost control to sustain long-term financial health.

Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model

Company Description

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.

How the Company Makes Money

Concentra Group Holdings Parent, Inc. generates revenue through several key streams, primarily by owning and operating subsidiary companies in its diversified portfolio. These subsidiaries contribute to the company's earnings by providing products and services in their respective markets, such as technology solutions, real estate investments, and financial services. The revenue model includes direct sales from products, service contracts, and leasing income from real estate holdings. Additionally, strategic partnerships with other firms in complementary sectors help expand market reach and generate additional income through collaborative projects and joint ventures. The company's ability to leverage its resources and expertise across its sectors enhances profitability and positions it for long-term growth.

Concentra Group Holdings Parent, Inc. Financial Statement Overview

Summary

Concentra Group Holdings Parent, Inc. shows solid revenue growth and improved leverage management. However, declining profit margins and negative free cash flow growth pose potential risks. The company needs to focus on enhancing profitability and cash flow generation to strengthen its financial position further.

Income Statement

Concentra Group Holdings Parent, Inc. has shown consistent revenue growth with a TTM growth rate of 4.15%. The gross profit margin has improved slightly to 28.36% in the TTM, indicating better cost management. However, the net profit margin has decreased to 7.33% from 8.76% in the previous year, reflecting a decline in profitability. The EBIT and EBITDA margins have also decreased, suggesting potential challenges in operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has improved significantly in the TTM to 1.39 from a high of 7.08 in the previous year, indicating better leverage management. However, the return on equity has decreased to 46.76% from 60.41%, which could be a concern for investors. The equity ratio remains stable, suggesting a balanced asset structure.

Cash Flow

The operating cash flow to net income ratio is strong at 0.81, indicating good cash generation relative to net income. However, the free cash flow growth rate is negative at -6.07%, which could signal potential cash flow challenges. The free cash flow to net income ratio remains healthy at 0.69, showing that the company is still generating adequate free cash flow relative to its net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	2.09B	1.90B	1.84B	1.72B
Gross Profit	592.56M	527.98M	512.43M	408.19M
EBITDA	393.68M	368.26M	360.15M	330.20M
Net Income	153.24M	166.54M	179.95M	166.73M
Balance Sheet
Total Assets	2.84B	2.52B	2.49B	2.30B
Cash, Cash Equivalents and Short-Term Investments	49.94M	183.25M	31.37M	37.66M
Total Debt	2.14B	1.95B	905.00M	1.04B
Total Liabilities	2.43B	2.22B	1.31B	1.30B
Stockholders Equity	385.49M	275.67M	1.16B	973.32M
Cash Flow
Free Cash Flow	175.56M	210.35M	164.98M	228.35M
Operating Cash Flow	254.42M	274.68M	234.32M	274.34M
Investing Cash Flow	-411.41M	-71.27M	-75.31M	-57.75M
Financing Cash Flow	70.11M	-51.53M	-165.29M	-209.86M

Concentra Group Holdings Parent, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.28
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Positive. The current price of 20.28 is above the 20-day moving average (MA) of 19.81, above the 50-day MA of 19.74, and below the 200-day MA of 20.76, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 55.74 is Neutral, neither overbought nor oversold. The STOCH value of 80.99 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CON.

Concentra Group Holdings Parent, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LH	70 Outperform	$20.76B	24.94	10.14%	1.14%	8.28%	97.24%
FLOC	70 Outperform	$1.72B	38.26	―	1.32%	―	―
NVST	69 Neutral	$3.84B	277.87	0.50%	―	4.73%	―
CON	65 Neutral	$2.64B	17.03	46.21%	1.27%	―	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
BBNX	50 Neutral	$777.03M	-9.64	-47.52%	―	67.01%	-39.19%
SPAI	39 Underperform	$118.08M	―	-193.70%	―	―	―

Concentra Group Holdings Parent, Inc. Corporate Events

Concentra Showcases Growth and Scale at Healthcare Conference

In an investor presentation prepared for the J.P. Morgan Healthcare Conference in January 2026, Concentra highlighted its position as the dominant U.S. occupational health provider, treating about one in four workplace injuries and operating more than 1,000 locations with multiple delivery channels. As of the twelve months ended September 30, 2025, the company reported $2.1 billion in revenue, a 19.8% adjusted EBITDA margin and $176 million in free cash flow, underpinned by largely inflation‑tracking fee‑for‑service pricing, minimal exposure to government reimbursement risk and long‑tenured direct relationships with major employers. Management emphasized the use of non‑GAAP metrics such as Adjusted EBITDA, Adjusted Net Income, ROIC and Free Cash Flow to evaluate segment performance and allocate resources, framing Concentra’s scale, diversified customer base and lower cost per claim as key competitive advantages for investors and employer stakeholders.

The most recent analyst rating on (CON) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Awards Restricted Shares to Executives

On November 4, 2025, Concentra Group Holdings Parent, Inc. awarded restricted shares of its common stock to its named executive officers under the 2024 Equity Incentive Plan. The shares will vest equally over four years, impacting the compensation structure and potentially aligning executive interests with company performance.

The most recent analyst rating on (CON) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Group Reports Strong Q3 2025 Financial Results

Concentra Group Holdings Parent, Inc. announced its third-quarter 2025 financial results, reporting a 17% increase in revenue to $572.8 million and an 8.9% rise in net income to $49.8 million compared to the same period in 2024. The company declared a cash dividend of $0.0625 per share and authorized a $100 million share repurchase program. These moves, alongside strong financial performance and strategic initiatives, position Concentra to enhance its market presence and deliver improved outcomes for stakeholders.

The most recent analyst rating on (CON) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.